What is Graph?
Graph operates as an AI-driven platform specifically engineered to optimize patient safety and regulatory compliance. The company provides a unified ecosystem that streamlines complex safety workflows, including adverse event intake, automated case processing, and comprehensive risk management. By integrating these disparate functions into a single, cohesive architecture, Graph enables life sciences companies to maintain strict adherence to global health authority standards while reducing the operational friction typically associated with manual reporting.
The platform's market position is defined by its focus on high-stakes compliance, where accuracy and speed are paramount. By leveraging advanced machine learning models, Graph transforms raw clinical data into actionable insights, effectively mitigating risk and enhancing the overall safety profile of medical products throughout their lifecycle.
How much funding has Graph raised?
Graph has raised a total of $3M across 1 funding round:
Seed
$3M
Seed (2025): $3M with participation from Bessemer Venture Partners
Key Investors in Graph
Bessemer Venture Partners
Bessemer Venture Partners is a prominent venture capital firm with a long history of backing transformative technology companies across various stages of growth.
What's next for Graph?
Looking ahead, the strategic deployment of this capital will likely focus on expanding the platform's analytical capabilities and broadening its footprint across international markets. As regulatory landscapes continue to evolve, the demand for automated, AI-centric compliance tools is expected to rise, providing Graph with a significant growth runway. The company is poised to transition from its current development phase into a period of aggressive scaling, prioritizing the integration of predictive analytics to further enhance its risk management suite. By maintaining its focus on enterprise-grade reliability, Graph is set to become an indispensable partner for organizations navigating the intersection of innovation and patient safety.
See full Graph company page
